This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Vivoryon Therapeutics N.v.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Michael Wermann: Innovator in Pharmaceutical Research
Introduction
Michael Wermann is a notable inventor based in Halle, Germany. He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds for medical applications. His work focuses on inhibitors of meprin α and β, which are crucial in treating various diseases.
Latest Patents
Wermann holds a patent for "Inhibitors of meprin α and β." This invention relates to novel hydroxamic acid derivatives that serve as inhibitors of meprin β and/or α. The patent also includes pharmaceutical compositions comprising these compounds, along with methods for the treatment or prophylaxis of diseases related to meprin β and/or α.
Career Highlights
Michael Wermann is currently associated with Vivoryon Therapeutics N.V., a company dedicated to developing innovative therapies for serious diseases. His expertise in pharmaceutical chemistry has been instrumental in advancing the company's research initiatives.
Collaborations
Wermann collaborates with Mirko Buchholz, a fellow researcher, to further explore the potential of their inventions in the pharmaceutical industry.
Conclusion
Michael Wermann's contributions to pharmaceutical research and his innovative patent on meprin inhibitors highlight his role as a key figure in the field. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile